Bernd Antje S, Aihara Makoto, Lindsey James D, Weinreb Robert N
Hamilton Glaucoma Center and Department of Ophthalmology, University of California San Diego, La Jolla, California 92093, USA.
Invest Ophthalmol Vis Sci. 2004 Feb;45(2):480-4. doi: 10.1167/iovs.03-0462.
Uveoscleral outflow provides a potential pathway to the posterior segment for drug delivery. In this study, the influence of molecular weight on the intraocular distribution of dextran molecules after intracameral injection in the mouse eye was investigated.
The anterior chambers of the eyes of 64 anesthetized NIH Swiss mice were perfused with various fluorescent dextran solutions (10, 40, 70, and 500 kDa) at 500 nL/min for 10 minutes. At 10, 20, or 60 minutes after the initiation of the anterior chamber perfusion, the mice were killed and tissue obtained for evaluation by fluorescence microscopy.
Each of the different molecular weight dextrans were visible in the anterior chamber of the mouse eye after the termination of the experiments. The 10-kDa dextran was observed in the supraciliary space and the supraciliary sclera after 10 minutes and in the anterior sclera after 60 minutes of perfusion. The 40-kDa dextran was detected in the supraciliary space and the anterior sclera after 10 minutes and in the anterior choroid and sclera after 20 and 60 minutes, but not in the posterior segment. The 70-kDa dextran was observed in the supraciliary space and anterior choroid after 10 minutes. After 20 minutes, it was visible in the equatorial choroid. After 60 minutes, it was observed in the posterior choroid. The 500-kDa dextran was observed in the supraciliary space and the anterior choroid after 10 minutes and in the supraciliary sclera at 20 minutes. At 60 minutes, 500-kDa dextran was observed in the equatorial choroid, but not farther toward the posterior.
The influence of molecular weight on the redistribution of macromolecules from the anterior chamber to the posterior globe in the mouse eye appears to be similar to primate eyes. These similarities include passage of all size dextrans through the proximal uveoscleral pathway, the dependence of the extent of posterior movement on the size of the dextran, and the absence of large dextran entry into the distal uveoscleral pathway.
葡萄膜巩膜流出途径为药物递送至眼后段提供了一条潜在通路。在本研究中,研究了分子量对小鼠眼前房注射后葡聚糖分子眼内分布的影响。
以500 nL/分钟的速度向64只麻醉的NIH瑞士小鼠的眼前房灌注各种荧光葡聚糖溶液(10、40、70和500 kDa),持续10分钟。在前房灌注开始后10、20或60分钟,处死小鼠并获取组织,通过荧光显微镜进行评估。
实验结束后,不同分子量的葡聚糖在小鼠眼前房中均可见。灌注10分钟后,10 kDa的葡聚糖出现在睫状体上腔和睫状体上巩膜,灌注60分钟后出现在前巩膜。40 kDa的葡聚糖在灌注10分钟后出现在睫状体上腔和前巩膜,在灌注20和60分钟后出现在脉络膜前部和巩膜,但未出现在眼后段。70 kDa的葡聚糖在灌注10分钟后出现在睫状体上腔和脉络膜前部。20分钟后,在赤道部脉络膜可见。60分钟后,在脉络膜后部可见。500 kDa的葡聚糖在灌注10分钟后出现在睫状体上腔和脉络膜前部,20分钟后出现在睫状体上巩膜。60分钟时,500 kDa的葡聚糖出现在赤道部脉络膜,但未进一步向后部延伸。
分子量对小鼠眼内大分子从前房向后部眼球重新分布的影响似乎与灵长类动物眼相似。这些相似之处包括所有大小的葡聚糖都通过近端葡萄膜巩膜途径,后部移动的程度取决于葡聚糖的大小,以及大分子量葡聚糖未进入远端葡萄膜巩膜途径。